Veristat Acquires SQN Clinical

Veristat Acquires Instat Clinical Research

October 19, 2023

Healthcare Services

Veristat, a full-service clinical research organization, has acquired Instat Clinical Research, a biometrics-focused CRO with teams in the United States and India. The deal expands Veristat's biometrics, data management, biostatistics, and statistical programming capabilities while adding offshore capacity to enable round-the-clock support for clinical studies.

Veristat Acquires The Clinical Trial Company Ltd (TCTC Group)

January 6, 2020

Healthcare Services

Veristat, a full-service CRO based in Southborough, Massachusetts, has acquired The Clinical Trial Company Ltd (TCTC Group), a Europe-headquartered contract research organization. The deal expands Veristat's European footprint and adds TCTC's expertise in gene and cell therapy, CNS and orphan disease clinical trials to Veristat's service offering.

Veristat Acquires SFL (Solutions for Life Sciences)

March 7, 2022

Healthcare Services

Veristat, a scientific-focused global CRO headquartered in Southborough, Massachusetts, has acquired SFL (Solutions for Life Sciences), a Basel-based multi-disciplinary life sciences consultancy. The acquisition expands Veristat's regulatory affairs, pharmacovigilance, medical writing, market access and quality assurance capabilities in Europe and strengthens its ability to support biopharma and medtech clients entering EU/UK/Swiss markets.

Versiti Acquires Quantigen

July 10, 2023

Healthcare Services

Versiti, a national blood health organization headquartered in Milwaukee, has acquired Quantigen, a specialty laboratory and contract research organization based in Fishers, Indiana. The acquisition expands Versiti’s clinical-trials and diagnostic capabilities—adding assay development, biomarker validation, and regulatory support for preclinical and clinical research.

SCI Solutions Acquires DatStat

April 4, 2018

Healthcare Services

SCI Solutions has acquired DatStat to combine its patient access and care coordination software with DatStat's digital patient engagement and clinical research data-collection tools. The acquisition creates an integrated patient access and engagement offering for providers and research institutions, with the combined company headquartered in Seattle. Financial terms were not disclosed.

WindRose Health Investors Recapitalizes Veristat Group Inc.

April 7, 2021

Healthcare Services

WindRose Health Investors completed an equity recapitalization of Veristat Group Inc., a global clinical research organization, with Veristat management retaining a significant minority stake. The investment will provide capital and strategic resources to support Veristat's growth and expansion across clinical development, regulatory affairs, biostatistics, data management and pharmacovigilance; terms were not disclosed.